General Information of Drug (ID: DM2S8W3)

Drug Name
Sc Veltuzumab
Indication
Disease Entry ICD 11 Status REF
Idiopathic thrombocytopenic purpura 3B64.10 Phase 1 [1]
Rheumatoid arthritis FA20 Phase 1 [1]
Drug Type
Monoclonal antibody
Cross-matching ID
TTD ID
D0D8NG
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia. Leuk Lymphoma. 2015 Oct 19:1-9.